75FCMC22F0001

EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL

Research the contractor View USAspending source Save to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

Field	Reported value
Agency	Department of Health and Human Services
Office	OFC OF ACQUISITION AND GRANTS MGMT
NAICS	541720 — Research and Development in the Social Sciences and Humanities
PSC	R499 — Other Professional Services
Parent award / vehicle	75FCMC19D0096
Set-aside	Not reported
Pricing type	COST PLUS FIXED FEE
Obligations	$24.5M
Current contract value	$24.5M
Potential contract value / ceiling	$24.5M
Start date	Feb 25, 2022
Current end date	Aug 24, 2029
Potential end date	Aug 24, 2029
Latest award activity	Mar 23, 2026
Source loaded	Sep 26, 2026

Funding and modification history

Showing the latest 11 of 11 loaded transactions. Negative values are deobligations.

Date	Modification	Obligation change	Description
Mar 23, 2026	P00010	$0	DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL (ETC) AND THE KIDNEY CARE CHOICES MODEL (KCC)
Feb 13, 2026	P00009	$7.9M	DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL (ETC) AND THE KIDNEY CARE CHOICES MODEL (KCC)
Jan 30, 2026	P00008	$0	DESIGN AND CARRY OUT AN INDEPENDENT EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL (ETC) AND THE KIDNEY CARE CHOICES MODEL (KCC)
Jun 16, 2025	P00007	$-4.8M	EOI::IMPLEMENTING THE PRESIDENT'S DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (FEB. 26, 2025)::EOI BILATERAL MODIFICATION TO DESCOPE TASK ORDER IN ACCORDANCE WITH EO 14222
Sep 13, 2024	P00006	$0	EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL
Aug 14, 2024	P00005	$0	EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL
May 7, 2024	P00004	$0	EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL
Oct 30, 2023	P00003	$0	EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL
Mar 21, 2023	P00002	$0	EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL
Dec 19, 2022	P00001	$0	EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL
Feb 25, 2022	0	$21.3M	EVALUATION OF THE END-STAGE RENAL DISEASE TREATMENT CHOICES MODEL AND THE KIDNEY CARE CHOICES MODEL

Estimated positioning window

Aug 24, 2028 – Feb 24, 2029

Recompete signal:

55/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 55/100. Available recorded signals: 50 points.

Contract end 2029-08-24 (1034 days from calculation): +15 points
126 historical awards in this buyer and category group: +15 points
11 recorded award transactions: +10 points
Latest award action: 2026-03-23: +5 points
Parent award identifier recorded: +5 points
Solicitation identifier recorded: +0 points
Linked official forecast: +0 points
Calculated on: 2026-10-25 10:18:04.631876+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Oct 25, 2026.

Research next steps

Check the linked forecast or SAM for a confirmed solicitation and current timing.
Confirm the ordering vehicle and your eligibility or a qualified teaming route.
Review the award scope and buyer evidence before making a bid/no-bid decision.